MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells
Cell Biochemistry and Biophysics · 2025
DOI: 10.1007/s12013-025-01722-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Ming-Qiang Chu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Leukemia, Erythroblastic, Acute. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Acute erythroid leukemia (AEL) is a rare acute myeloid leukemia (AML) subtype that is highly aggressive and is associated with a poor prognosis. Notably, the blockage of erythroid differentiation represents a significant factor in the pathogenesis of erythroleukemia. Prior studies indicated that miR-218 inhibited the erythroid differentiation in a chronic myeloid leukemia (CML)-derived erythroleukemia cell line K562. However, functions of miR-218 in primary AEL remains to be elucidated. To address this gap, functions of miR-218 in HEL cells were evaluated through cell differentiation, cell proliferation, colony formation, cell cycle and cell apoptosis experiments. Subsequently, the targeted downstream genes of miR-218 were identified by the transcriptome sequencing and bioinformatic research, of which demonstrated by the dual-luciferase reporter experiment. Finally, the underlying mechanism of miR-218 in leukemogenesis was identified by enrichment analysis and was validated by western blot (WB) assays. Intriguingly, enhanced miR-218 showed no effect on the erythroid differentiation in HEL cells by determination of the expression of erythroid markers including GATA1, KLF1, TFRC and GYPA. However, miR-218 overexpression in HEL cells presented a markedly anti-proliferative and pro-apoptotic effects, inhibited colony formation and G0/G1 arrest. Transcriptome sequencing and bioinformatics analysis revealed that CTNND2 as the candidate gene of miR-218 within its 3'-untranslated region (3'-UTR) could be bonded by it. Reduced expression level of CTNND2 was further demonstrated by quantitative-PCR and WB after miR-218 overexpression in HEL cells. Furthermore, the luciferase report assay revealed that the CTNND2 production was reduced with its 3'-UTR region was bonded by miR-218. In addition, MAPK signaling pathway was identified and validated as the potential functional pathway involved in leukemogenesis caused by miR-218 overexpression in HEL cells. In summary, miR-218 exhibits anti-proliferative and pro-apoptotic functions by targeting CTNND2 and modulating MAPK signaling in HEL cells, yet it has no impact on the erythroid differentiation process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
- Institute of Hematology, Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
- Zhenjiang Clinical Research Center of Hematology, Zhenjiang, Jiangsu, People's Republic of China.
- The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, People's Republic of China.
- Laboratory Center, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
- Department of Oncology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
Förderung
- Graduate Research and Innovation Projects of Jiangsu Province
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Social Development Foundation of Zhenjiang
- Research Project of Jiangsu Commission of Health
Zitieren
APA
Chu, M. Q., Zhang, T. J., Liu, Z. Q., Yang, Q., Du, T. T., Zhang, M. J., Jin, Y., Cao, Y. J., Wen, X. M., Xu, Z. J., Zhao, Y. J., Lin, J., Qian, J., & Zhou, J. D. (2025). MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-025-01722-5
Vancouver
Chu MQ, Zhang TJ, Liu ZQ, Yang Q, Du TT, Zhang MJ, et al. MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-025-01722-5
BibTeX
@article{Chu2025,
author = {Chu, Ming-Qiang and Zhang, Ting-Juan and Liu, Zi-Qi and Yang, Qian and Du, Ting-Ting and Zhang, Min-Jie and Jin, Ye and Cao, Yong-Jie and Wen, Xiang-Mei and Xu, Zi-Jun and Zhao, Yang-Jing and Lin, Jiang and Qian, Jun and Zhou, Jing-Dong},
title = {MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells},
journal = {Cell Biochemistry and Biophysics},
year = {2025},
doi = {10.1007/s12013-025-01722-5}
}
EUVIMED